Andreas Rothfuss, PhD, DABT, is a Scientific Strategy Lead and Chapter Lead in Enabling Sciences at Roche. They served as a Postdoctoral Fellow in the Department of Molecular and Medical Genetics at OHSU from 2002 to 2003, and later held positions as Principal Scientist in Early and Mechanistic Toxicology at Schering from 2004 to 2007. Their expertise further developed at Bayer HealthCare, where they were the Head of Genetic and Mechanistic Toxicology from 2010 to 2011, and they took on various leadership roles at Roche Pharmaceuticals from 2011 to 2022, culminating in their current position.
This person is not in the org chart
This person is not in any teams
This person is not in any offices